|
Re: Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?
|
4
|
Resverlogix Corp.
|
May 17, 2017 12:29PM
|
|
Re: 2019 Potential Events
|
4
|
Resverlogix Corp.
|
Jan 24, 2019 10:05AM
|
|
Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study
|
4
|
Zenith Epigenetics
|
Sep 04, 2018 08:52AM
|
|
Re: Nice volume surge at the end....
|
4
|
Resverlogix Corp.
|
Jun 28, 2017 10:45AM
|
|
Re: RVX 297 publication news from rndtbl from IV
|
4
|
Resverlogix Corp.
|
Oct 04, 2017 09:40AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
4
|
Resverlogix Corp.
|
Mar 26, 2020 06:41PM
|
|
Re: What Are Our Reasonable Expectations?
|
4
|
Zenith Epigenetics
|
Feb 08, 2016 12:06PM
|
|
Re: Epigenetics: an exciting new approach in prostate cancer
|
4
|
Zenith Epigenetics
|
Apr 10, 2019 09:15AM
|
|
Re: BRD2 involvement in Covid19
|
4
|
Resverlogix Corp.
|
Mar 18, 2020 10:26PM
|
|
Re: Q2 Zenith/Resverlogix Events
|
4
|
Zenith Epigenetics
|
Apr 17, 2016 02:11PM
|
|
April Fact Sheet
|
4
|
Resverlogix Corp.
|
Apr 10, 2019 09:20AM
|
|
Re: No answer yet on what the change in study protocol is....
|
4
|
Resverlogix Corp.
|
Jul 28, 2017 02:13PM
|
|
8 weeks into ZEN-3694 trial today
|
4
|
Zenith Epigenetics
|
Aug 10, 2016 05:13PM
|
|
Re: “We will see how close we got”.....
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 08:14AM
|
|
Re: Zenith Epigenetics Announces Publication of Covalent Bromodomain Inhibitors, Offering a Novel Approach to Targeting BET Bromodomains
|
4
|
Zenith Epigenetics
|
Oct 02, 2018 10:27AM
|
|
Re: Jardiance??
|
4
|
Resverlogix Corp.
|
Oct 17, 2018 12:23PM
|
|
Re: HDL Functionality
|
4
|
Resverlogix Corp.
|
May 06, 2019 11:47AM
|
|
Patent Application Publication 10/31/2019 CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD. (Suzhou, Jiangsu, CN)
|
4
|
Resverlogix Corp.
|
Nov 03, 2019 10:27PM
|
|
Re: Looking for clues:
|
4
|
Resverlogix Corp.
|
Nov 30, 2019 02:33PM
|
|
Re: RVX AHA Presentation 191116 - CORRECTED AGAIN (same as last correction in other message)
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 08:20AM
|
